E5202
|
ECOG
|
A Randomized Phase III Study Comparing 5-FU; Leucovorin and Oxaliplatin Versus 5-FU; Leucovorin; Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E5204
|
ECOG
|
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin; 5-Fluorouracil; and Leucovorin vs Oxaliplatin; 5-Fluorouracil; Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-Operative Chemoradiation
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E5508
|
ECOG
|
Randomized Phase III Study of Maintenance Therapy with Bevacizumab; Pemetrexed; or a Combination of Bevacizumab and Pemetrexed Following Carboplatin; Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E6201
|
ECOG
|
A Phase III; Randomized Study of Gemcitabine [fixed-dose rate infusion] and Oxaliplatin (NSC 266046) versus Gemcitabine [fixed-dose rate infusion] versus Gemcitabine [30-minute infusion] in Pancreatic Carcinoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
EA1131
|
ECOG-ACRIN
|
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA1141
|
ECOG-ACRIN
|
Comparison of Abbreviated Breast MRI and Digital Breast Tomosynthesis in Breast Cancer Screening in Women with Dense Breasts
|
Cancer Prevention and Control CIRB
|
Completed
|
|
EA1151
|
ECOG-ACRIN
|
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
EA1181
|
ECOG-ACRIN
|
(CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA1183
|
ECOG-ACRIN
|
FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
EA1211
|
ECOG-ACRIN
|
Interim FDG-PET/CT for PreDIcting REsponse of HER2+ Breast Cancer to Neoadjuvant Therapy: DIRECT trial
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|